TY - JOUR
T1 - Drug Interactions in Hypertensive Patients
T2 - Pharmacokinetic, Pharmacodynamic and Genetic Considerations
AU - Francis Lam, Y. W.
AU - Shepherd, Alexander M.M.
PY - 1990/4
Y1 - 1990/4
N2 - Antihypertensive treatment has proven benefits, and the number of patients being treated with these drugs is significant. Hypertensive patients may have other medical illnesses for which they receive medications, and interactions between antihypertensive agents and other drugs is likely. Some of these interactions may lead to undesirable effects or even loss of blood pressure control. However, drug interactions can also be beneficial when 2 antihypertensive drugs with different pharmacological actions are prescribed in combination and with a clear therapeutic objective in mind. Clinicians should be aware of the mechanisms and the consequences of the different types of interaction in hypertensive patients, so that a desired pharmacological response can be achieved with the fewest side effects in the patients.
AB - Antihypertensive treatment has proven benefits, and the number of patients being treated with these drugs is significant. Hypertensive patients may have other medical illnesses for which they receive medications, and interactions between antihypertensive agents and other drugs is likely. Some of these interactions may lead to undesirable effects or even loss of blood pressure control. However, drug interactions can also be beneficial when 2 antihypertensive drugs with different pharmacological actions are prescribed in combination and with a clear therapeutic objective in mind. Clinicians should be aware of the mechanisms and the consequences of the different types of interaction in hypertensive patients, so that a desired pharmacological response can be achieved with the fewest side effects in the patients.
UR - http://www.scopus.com/inward/record.url?scp=0025253036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025253036&partnerID=8YFLogxK
U2 - 10.2165/00003088-199018040-00003
DO - 10.2165/00003088-199018040-00003
M3 - Article
C2 - 2182265
AN - SCOPUS:0025253036
SN - 0312-5963
VL - 18
SP - 295
EP - 317
JO - Clinical Pharmacokinetics
JF - Clinical Pharmacokinetics
IS - 4
ER -